adenosine has been researched along with Psychotic Disorders in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Davis, JM; Gershon, AA; Keefe, RS; Ladea, M; Petcu, C; Podea, D; Rubinstein, K; Sima, D; Weiser, M | 1 |
Boison, D; Chen, JF; Lan, JQ; Lytle, N; Shen, HY; Singer, P; Wei, CJ; Williams-Karnesky, RL; Yee, BK | 1 |
da Silva, AL; Dall'Igna, OP; Hoffmann, A; Lara, DR; Souza, DO | 1 |
Gotoh, L; Hirano, M; Hondo, H; Kanchiku, I; Kawanami, N; Kuroki, T; Motomura, K; Nakahara, T; Ohta, E; Uchimura, H | 1 |
1 trial(s) available for adenosine and Psychotic Disorders
Article | Year |
---|---|
A randomized controlled trial of allopurinol vs. placebo added on to antipsychotics in patients with schizophrenia or schizoaffective disorder.
Topics: Adenosine; Adult; Allopurinol; Antipsychotic Agents; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Psychotic Disorders; Schizophrenia; Treatment Outcome; Xanthine Oxidase | 2012 |
3 other study(ies) available for adenosine and Psychotic Disorders
Article | Year |
---|---|
Adenosine augmentation ameliorates psychotic and cognitive endophenotypes of schizophrenia.
Topics: Adenosine; Adenosine Kinase; Amphetamines; Animals; Antipsychotic Agents; Basal Ganglia; Cell Transplantation; Cells, Cultured; Cognition Disorders; Cricetinae; Disease Models, Animal; Endophenotypes; Hippocampus; Mice; Mice, Inbred C57BL; Mice, Transgenic; Morpholines; Psychotic Disorders; Pyrimidines; Receptor, Adenosine A2A; Schizophrenia; Schizophrenic Psychology | 2012 |
Beta-amyloid treatment sensitizes mice to amphetamine-induced locomotion but reduces response to caffeine.
Topics: Adenosine; Adrenergic Agents; Alzheimer Disease; Amphetamine; Amyloid beta-Peptides; Animals; Avoidance Learning; Brain; Caffeine; Central Nervous System Stimulants; Disease Models, Animal; Dizocilpine Maleate; Dopamine; Excitatory Amino Acid Antagonists; Glutamine; Injections, Intraventricular; Male; Mice; Motor Activity; Psychotic Disorders | 2004 |
Effects of the adenosine A(1) receptor agonist N(6)-cyclopentyladenosine on phencyclidine-induced behavior and expression of the immediate-early genes in the discrete brain regions of rats.
Topics: Adenosine; Animals; Antipsychotic Agents; Brain; Cytoskeletal Proteins; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Gene Expression; Genes, Immediate-Early; Gyrus Cinguli; Hallucinogens; Head Movements; Male; Motor Activity; Nerve Tissue Proteins; Nucleus Accumbens; Phencyclidine; Prefrontal Cortex; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Psychotic Disorders; Purinergic P1 Receptor Agonists; Rats; Rats, Wistar; Receptors, Purinergic P1; RNA, Messenger | 2002 |